Related Experiment Video
Updated: Jan 11, 2026

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
Cognitive impairment in chronic inflammatory demyelinating polyneuropathy
Oliver L Steiner1,2,3, Claudia Angela4,5, Elena Krasivskaya4
1Motor and Cognition Group, Department of Neurology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Benjamin Franklin (CBF), Hindenburgdamm 30, 12203, Berlin, Germany. oliver.steiner@charite.de.
Introduction:
Cognitive dysfunction has been repeatedly described as an aspect of chronic inflammatory demyelinating polyneuropathy (CIDP), but to which capacities this exactly refers and how it is embedded in the clinical phenotype of the condition remains unknown. Therefore, the detailed cognitive profiles of persons with and without CIDP were compared with each other and the disease-related results analyzed in view of main symptom complexes.
Methods:
44 persons with CIDP were studied with respect to their cognitive performances in an extensive computer-based test battery and described clinically in terms of sensorimotor disability (R-ODS), fatigue (FSMC), and mood (DESC-I). The cognitive test results were compared to those of 33 age-matched healthy controls.
Results:
The overall cognitive performance of persons with CIDP was significantly worse than that of controls (composite score for CIDP: 33.34 ± 17.96; for Controls: 48.73 ± 18.31; U = 382, p < 0.001). Pronounced deficits prevailed in processing speed (q = 0.018), executive function (q = 0.018), memory (short-term: q = 0.020; long-term: q = 0.025) and visuoconstruction (q = 0.018). Using a hierarchical regression model, the inclusion of the factor sensorimotor disability improved the prediction of overall cognitive performance in persons with CIDP (p = 0.027).
Conclusion:
Cognitive impairment is an under-recognized aspect of CIDP, characterized by reduced processing speed, executive functioning, and memory performance. These cognitive deficits grow together with sensorimotor impairment. The findings show that CIDP goes along with functional changes beyond its classical lead symptoms.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12:23Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists